Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
diagnostics
immunotherapy
indiana blog main
indiana top stories
life sciences
medicare
merck
national
national blog main
national top stories
2
×
new york blog main
new york top stories
novartis
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
roche
2
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
sickle cell disease
spark therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
abeona therapeutics
What
bio
2
×
drug
patients
2
×
roundup
acquisitions
advantages
albert
bar
biggest
bourla
brings
ceo
company
crispr
expect
future
gamble
imports
maker
maps
market
measured
medco’s
mover
new
payers
pfizer
pfizer’s
physicians
plan
pricing
revenue
sets
today
type
ubiome
undone
vertex’s
world’s
Language
unknown
unset
Current search:
roche
×
patients
×
bio
×
amgen
×
" national top stories "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More